Macro Group Pharmaceuticals (Macro Capital) S.A.E Share Price
Stocks
MCRO
EGS7D971C011
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.350 EGP | +1.50% |
|
+6.30% | +18.42% |
| 17/05 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 20/02 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 77Cr 1.53Cr 1.34Cr 1.24Cr 1.15Cr 2.17Cr 146.65Cr 2.21Cr 15Cr 5.82Cr 72Cr 5.75Cr 5.63Cr 248.71Cr | P/E 2026 * |
22.5x | P/E 2027 * | 15x |
|---|---|---|---|---|---|
| Enterprise Value | 69Cr 1.37Cr 1.2Cr 1.12Cr 1.03Cr 1.94Cr 131.46Cr 1.98Cr 13Cr 5.22Cr 65Cr 5.16Cr 5.05Cr 222.96Cr | EV / Sales 2026 * |
0.58x | EV / Sales 2027 * | 0.43x |
| Free-Float |
96.11% | Yield 2026 * |
2.22% | Yield 2027 * | 2.96% |
| 1 day | +1.50% | ||
| 1 week | +6.30% | ||
| Current month | +12.50% | ||
| 1 month | +11.57% | ||
| 3 months | +20.54% | ||
| 6 months | +21.62% | ||
| Current year | +18.42% |
| 1 week | 1.23 |  | 1.37 |
| 1 month | 1.17 | | 1.37 |
| Current year | 1.02 | | 1.68 |
| 1 year | 0.81 | | 4.11 |
| 3 years | 0.81 | | 4.11 |
| 5 years | 0.81 | | 5.28 |
| 10 years | 0.81 | | 5.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Khaled Kamel
CEO | Chief Executive Officer | - | - |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
Tamer Raouf
SAM | Sales & Marketing | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Sahar El-Sallab
BRD | Director/Board Member | - | 01/01/2021 |
Ahmed Badreldin
BRD | Director/Board Member | 54 | 01/01/2021 |
Ahmed El-Nayeb
CHM | Chairman | - | 01/01/2002 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.50% | +6.30% | -38.64% | -51.09% | 1.53Cr | |
| -0.56% | -1.52% | +49.04% | +171.88% | 1,06000Cr | |
| +0.31% | -0.60% | +64.29% | +62.31% | 62TCr | |
| -0.03% | -2.65% | +28.86% | +85.64% | 44TCr | |
| -1.75% | -0.33% | +28.78% | +23.58% | 33TCr | |
| +0.24% | -0.42% | +29.46% | +47.26% | 28TCr | |
| -1.75% | -10.57% | +20.67% | +22.07% | 27TCr | |
| +0.67% | +1.03% | -26.10% | -37.96% | 22TCr | |
| -0.81% | -1.63% | +22.07% | +58.33% | 20TCr | |
| +1.21% | +1.38% | +19.85% | +71.29% | 16TCr | |
| Average | -0.06% | -1.39% | +19.83% | +45.33% | 35.74TCr | |
| Weighted average by Cap. | -0.28% | -2.12% | +36.27% | +83.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 119Cr 2.37Cr 2.08Cr 1.92Cr 1.77Cr 3.35Cr 226.7Cr 3.41Cr 23Cr 8.99Cr 111.33Cr 8.89Cr 8.7Cr 384.47Cr | 155.2Cr 3.09Cr 2.71Cr 2.51Cr 2.31Cr 4.37Cr 295.67Cr 4.45Cr 30Cr 12Cr 145.2Cr 12Cr 11Cr 501.43Cr |
| Net income | 21Cr 41L 35.96L 33.31L 30.65L 57.97L 39Cr 59.1L 3.97Cr 1.56Cr 19Cr 1.54Cr 1.51Cr 67Cr | 28Cr 56.33L 49.41L 45.76L 42.1L 79.64L 54Cr 81.19L 5.45Cr 2.14Cr 26Cr 2.12Cr 2.07Cr 91Cr |
| Net Debt | -7.97Cr -15.86L -13.91L -12.89L -11.86L -22.43L -15Cr -22.86L -1.54Cr -60.24L -7.46Cr -59.57L -58.27L -26Cr | -11Cr -21.89L -19.2L -17.79L -16.37L -30.95L -21Cr -31.56L -2.12Cr -83.14L -10Cr -82.22L -80.42L -36Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | EGP 1.350 | +1.50% | 13,64,30,983 |
| 12/26/12 | EGP 1.330 | +6.40% | 10,86,76,405 |
| 09/26/09 | EGP 1.250 | +1.63% | 2,61,77,797 |
| 08/26/08 | EGP 1.230 | -2.38% | 1,80,53,225 |
| 07/26/07 | EGP 1.260 | -0.79% | 2,72,42,139 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.350EGP
Average target price
1.570EGP
Spread / Average Target
+16.30%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MCRO Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
